Prescription weight loss that puts you first

Get started

Switching From Tirzepatide to Semaglutide: What to Expect

Lynn Marie Morski

Reviewed by Lynn Marie Morski, MD, JD

Written by Vanessa Gibbs

Updated 11/25/2025

Key takeaways: 

  • You can switch from tirzepatide to semaglutide if tirzepatide isn’t working for you.

  • You may be able to take semaglutide 1 week after your last tirzepatide dose.

  • If you have tirzepatide side effects, your healthcare provider may suggest waiting until they subside before starting semaglutide.

  • To reduce side effects, you’ll likely start on a low dose of semaglutide, even if you were on a high dose of tirzepatide.


Medications aren’t lifelong contracts. You can switch from one to another — if it’s safe for you to do so and under the guidance of a healthcare provider, of course.

So, if you’re taking tirzepatide (Mounjaro®, Zepbound®) and it’s not working out for you, semaglutide (Ozempic®, Wegovy®) could be a good alternative to help you achieve your weight loss goals.

We’ll cover everything you need to know about switching from tirzepatide to semaglutide, including why you might do it, how to switch, and which side effects could crop up.

You can switch from tirzepatide to semaglutide. They’re both weight loss medications that work in similar ways.

But the drugs target different hormone receptors, so one might suit your body better or cause fewer side effects than the other.

However, you can’t take both medications at the same time. Your healthcare provider will let you know what to do, of course. But you’ll probably stop taking tirzepatide and start on a low dose of semaglutide that gradually increases — even if you were on a high dose of tirzepatide.

There are many reasons you might switch from tirzepatide to semaglutide, including:

  • Side effects. If tirzepatide side effects are bothering you and not getting better, semaglutide might cause fewer side effects.

  • Efficacy. Everyone reacts differently to medications. If tirzepatide isn’t affecting your hunger or cravings, semaglutide might work better for you.

  • Cost. Depending on where you get your medication, semaglutide medications are sometimes more affordable than tirzepatide medications.

  • Insurance coverage. Insurance plans don’t often cover weight loss drugs, but you might get coverage in some situations for semaglutide over tirzepatide.

  • Health conditions. Wegovy® is approved by the Food and Drug Administration (FDA) to reduce the risk of cardiovascular events in people with cardiovascular disease and overweight or obesity. Tirzepatide drugs don’t have this FDA approval.

  • Form. Semaglutide is available as a tablet under the brand name Rybelsus®. Rybelsus® is sometimes prescribed off-label for weight loss and chronic weight management. Tirzepatide is only available in weekly injections.

Tirzepatide and semaglutide are similar medications, but they’re not exactly the same. Here’s how they compare at a glance.

Tirzepatide
Semaglutide
Once-weekly injection
Once-weekly injection or daily pill
GLP-1 and GIP receptor agonist
GLP-1 receptor agonist
Suppresses hunger and makes you feel fuller
Suppresses hunger and makes you feel fuller
FDA-approved for type 2 diabetes (Mounjaro®) and weight loss or sleep apnea in people with obesity or overweight (Zepbound®)
FDA-approved for type 2 diabetes (Ozempic®, Rybelsus®) and weight loss and cardiovascular risk reduction in people with obesity or overweight (Wegovy®)
Primary side effects include nausea, vomiting, diarrhea, and constipation
Primary side effects include nausea, vomiting, diarrhea, and constipation

As you can see, tirzepatide is a GLP-1 (glucagon-like peptide-1) and a GIP (glucose-dependent insulinotropic polypeptide) receptor agonist. That means it activates both GLP-1 and GIP receptors in your body.

Semaglutide, on the other hand, is just a GLP-1, meaning it only activates GLP-1 receptors.

This difference means one medication may be more effective for weight loss or blood sugar control (or cause fewer side effects) than the other. It all depends on how your body reacts.

Which Is More Effective: Tirzepatide vs. Semaglutide?

Research suggests tirzepatide is more effective than semaglutide. A 2025 study found that Zepbound® led to an average weight loss of about 20 percent over 72 weeks, whereas Wegovy® led to an average weight loss of roughly 14 percent.

That said, everyone reacts differently to medications. Semaglutide might help you lose more weight, especially if tirzepatide side effects make it hard to exercise or stick to your treatment plan. Many people reach their weight loss goals on semaglutide.

To switch from tirzepatide to semaglutide, start by connecting with a healthcare provider. They can make sure semaglutide is right for you and walk you through the best way to switch.

Here are the steps:

  1. Connect with a healthcare professional. Your provider can go over your medical history and current health, ensure semaglutide is right for you, and write you a prescription if so. You can connect with a provider online through the Hers platform.

  2. Discontinue tirzepatide. Your provider will let you know how to do this. You may be able to take your first semaglutide injection 1 week after your last tirzepatide injection on your usual injection day. If you’re experiencing troubling side effects, your provider may recommend waiting for them to get better before starting semaglutide.

  3. Start semaglutide on a low dose. Your provider will probably prescribe a starting dose of 0.25 milligrams (mg) of semaglutide, even if you were on a higher dose of tirzepatide. Your dose will gradually increase every four weeks.

  4. Keep up healthy lifestyle changes. Like tirzepatide, semaglutide is prescribed alongside eating nutritious foods and doing more movement. Stick with new habits to promote healthy weight loss on your new medication.

Tirzepatide and semaglutide have similar side effects. For example, common side effects of Zebound and Wegovy® include:

  • Nausea

  • Vomiting

  • Constipation

  • Diarrhea

  • Abdominal pain

Wegovy® side effects are common when you first start the medication, but get better with time. So you might experience them when you switch, but things should improve.

Some research suggests that tirzepatide is more likely to cause gastrointestinal (GI) side effects than semaglutide. So, in the long run, you may feel better than you did before switching medications.

There’s another potential side effect to watch out for. Since you’re starting on a lower dose of semaglutide, you might experience more hunger and food cravings than you did when you were on tirzepatide.

To maintain your weight loss progress, stay on top of healthy lifestyle habits, like:

  • Eating nutritious foods, including protein and fiber, to stay fuller for longer

  • Drinking plenty of water

  • Doing more movement

  • Getting enough sleep

  • Being mindful of stress-eating or grazing when you’re not hungry

As your semaglutide dose increases, your hunger and cravings may go down, helping you continue your weight loss journey.

Read next: How to Lose Weight

Switching from tirzepatide to semaglutide is possible — as long as you’re a good candidate for semaglutide, of course.

Here are the key points one more time:

  • You can switch from tirzepatide to semaglutide. You might find that semaglutide causes fewer side effects, helps you lose more weight, improves your health in other ways, or is more affordable than tirzepatide.

  • You may be able to take tirzepatide 1 week after semaglutide. However, if you’re dealing with side effects, your healthcare provider may recommend waiting until these resolve before starting semaglutide.

  • Keep up healthy habits to reach your weight loss goals. Eating nutritious foods, doing more movement, getting enough sleep, and keeping stress levels low can help you lose weight as you switch from tirzepatide to semaglutide — and then beyond.

Your first step to switching weight loss medications is to connect with a healthcare provider. Take our free online weight loss quiz to see if you’re eligible for semaglutide.

Get answers to frequently asked questions about switching from tirzepatide to semaglutide below.

Is it safe to switch from tirzepatide to semaglutide?

Yes, it’s safe to switch from tirzepatide to semaglutide if a healthcare provider determines semaglutide is safe for you. You shouldn’t take both medications at the same time, but you can stop tirzepatide and start semaglutide afterward.

Is semaglutide stronger than tirzepatide?

Tirzepatide may be stronger than semaglutide. Some clinical trials show it can lead to greater weight loss. However, people react differently to different medications. So you might find that semaglutide is more effective for you for weight reduction, especially if you’re experiencing tirzepatide side effects.

How long does it take to adjust to semaglutide after switching?

There’s no set timeframe for how long it takes to adjust to semaglutide after switching from another medication. You might experience side effects when you first start taking semaglutide, but these should get better with time. For example, Ozempic® and Rybelsus® side effects tend to happen in the first 8 to 12 weeks.

Do you lose more muscle on tirzepatide or semaglutide? 

You may lose muscle on either tirzepatide or semaglutide as you’re losing body fat. To minimize muscle loss, strength train regularly and eat plenty of protein. Go for lean protein sources like chicken, turkey, fish, and tofu. And do strength exercises at least twice a week with bodyweight exercises, dumbbells, or resistance machines.

Read next: How Much Protein Should You Eat for Weight Loss?

This article is for informational purposes only and does not constitute medical advice. The information contained herein is not a substitute for and should never be relied upon for professional medical advice. Always talk to your doctor about the risks and benefits of any treatment. Learn more about our editorial standards.

10 Sources

  1. Almandoz JP, et al. (2020). Switching between glucagon-like peptide-1 receptor agonists: rationale and practical guidance. https://pmc.ncbi.nlm.nih.gov/articles/PMC7566932/
  2. Aronne LJ, et al. (2025). Tirzepatide as compared with semaglutide for the treatment of obesity. https://www.nejm.org/doi/full/10.1056/NEJMoa2416394
  3. Mounjaro® (tirzepatide) injection, for subcutaneous use. (2025). https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/215866s034lbl.pdf
  4. Ozempic® (semaglutide) injection, for subcutaneous use. (2025). https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/209637s035,209637s037lbl.pdf
  5. Safwan M, et al. (2025). Gastrointestinal safety of semaglutide and tirzepatide vs. placebo in obese individuals without diabetes: a systematic review and meta-analysis. https://pmc.ncbi.nlm.nih.gov/articles/PMC12542916/
  6. Smits MM, et al. (2021). Safety of semaglutide. https://pmc.ncbi.nlm.nih.gov/articles/PMC8294388/
  7. U.S. Department of Health and Human Services. (2018). Physical Activity Guidelines for Americans. https://odphp.health.gov/sites/default/files/2019-09/Physical_Activity_Guidelines_2nd_edition.pdf
  8. Wegovy® (semaglutide) injection, for subcutaneous use. (2025). https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/215256s026lbl.pdf
  9. Wilding JPH, et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. https://www.nejm.org/doi/full/10.1056/NEJMoa2032183
  10. Zepbound® (tirzepatide) injection, for subcutaneous use. (2025). https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/217806s031lbl.pdf
Editorial Standards

Hims & Hers has strict sourcing guidelines to ensure our content is accurate and current. We rely on peer-reviewed studies, academic research institutions, and medical associations. We strive to use primary sources and refrain from using tertiary references. See a mistake? Let us know at [email protected]!

This article is for informational purposes only and does not constitute medical advice. The information contained herein is not a substitute for and should never be relied upon for professional medical advice. Always talk to your doctor about the risks and benefits of any treatment. Learn more about our editorial standards here.

Lynn Marie Morski, MD, JD

Basic Information

  • Full Name: Lynn Marie Morski, MD, JD

  • Current Role at Hims & Hers: Medical Advisor

Credentials & Background

Experience & Expertise

Contributions to Hims & Hers

  • Medical Content Reviewed & Approved:

    • List pages or topics the expert has reviewed for accuracy

  • Quotes or Expert Insights:

    • Mental health care isn’t a luxury, it’s a fundamental part of overall well-being. We all deserve mental health support that’s evidence-based, accessible, and affordable.

  • Media Mentions & Features:

    • A User’s Guide to Therapeutic Psychedelics: From magic mushrooms to MDMA and ayahuasca to ibogaine—everything you need to know before (and after) taking the leap - Oprah Daily, May 6, 2024

Personal & Humanizing Details

  • Why I Practice Medicine:

    • I'm passionate about helping people access reliable, affordable healthcare—without stigma or unnecessary barriers. Everyone deserves to feel informed and empowered when it comes to their health!

  • Hobbies & Interests:

    • Salsa dancing, drumming, surfing, scuba diving, triathlons

Contact & External Profiles

Read more

Related Articles

Get personalized treatment

Doctor-trusted treatment plans tailored to your unique needs